AARD (STOCKS)
Aardvark Therapeutics, Inc. Common Stock
$3.820000
+0.100000 (+2.69%)
Prev close: $3.720000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Tien Li Lee
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $82.90M
- Employees
- 31
- P/E (TTM)
- -1.19
- P/B (TTM)
- 0.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | -$1.18M |
| Nonoperating Income/Loss | $4.85M |
| Operating Expenses | $74.72M |
| Research and Development | $57.75M |
| Other Operating Expenses | $16.97M |
| Operating Income/Loss | -$74.72M |
| Income/Loss From Continuing Operations After Tax | -$69.87M |
| Income/Loss From Continuing Operations Before Tax | -$80.35M |
| Interest And Dividend Income, Operating | $4.85M |
| Net Income/Loss | -$69.87M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$69.87M |
| Net Income/Loss Available To Common Stockholders, Basic | -$69.87M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.21 |
| Diluted Earnings Per Share | -$3.21 |
| Basic Average Shares | 28,245,903 |
| Diluted Average Shares | 28,245,903 |
| Assets | $98.59M |
| Current Assets | $93.58M |
| Cash | $91.20M |
| Other Current Assets | $2.38M |
| Noncurrent Assets | $5.01M |
| Liabilities | $11.60M |
| Current Liabilities | $11.60M |
| Accounts Payable | $4.49M |
| Wages | $1.52M |
| Other Current Liabilities | $5.59M |
| Noncurrent Liabilities | $0.00 |
| Equity | $86.99M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $86.99M |
| Liabilities And Equity | $98.59M |
| Net Cash Flow From Operating Activities | -$61.65M |
| Net Cash Flow From Operating Activities, Continuing | -$61.65M |
| Net Cash Flow From Investing Activities | $97.21M |
| Net Cash Flow From Investing Activities, Continuing | $97.21M |
| Net Cash Flow From Financing Activities | $378.00K |
| Net Cash Flow From Financing Activities, Continuing | $378.00K |
| Net Cash Flow | $35.93M |
| Net Cash Flow, Continuing | $35.93M |
| Comprehensive Income/Loss | -$69.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$69.90M |
| Other Comprehensive Income/Loss | -$69.90M |